DK1083224T3 - Apoptin-associerende protein - Google Patents

Apoptin-associerende protein

Info

Publication number
DK1083224T3
DK1083224T3 DK00203042T DK00203042T DK1083224T3 DK 1083224 T3 DK1083224 T3 DK 1083224T3 DK 00203042 T DK00203042 T DK 00203042T DK 00203042 T DK00203042 T DK 00203042T DK 1083224 T3 DK1083224 T3 DK 1083224T3
Authority
DK
Denmark
Prior art keywords
apoptin
associating protein
novel therapeutic
novel
apoptosis
Prior art date
Application number
DK00203042T
Other languages
Danish (da)
English (en)
Inventor
Mathieu Hubertus Mari Noteborn
Oorschot Astrid Adri Danen-Van
Original Assignee
Leadd Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99202858A external-priority patent/EP1081226A1/fr
Priority claimed from EP99203465A external-priority patent/EP1108785A1/fr
Application filed by Leadd Bv filed Critical Leadd Bv
Application granted granted Critical
Publication of DK1083224T3 publication Critical patent/DK1083224T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK00203042T 1999-09-02 2000-09-01 Apoptin-associerende protein DK1083224T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202858A EP1081226A1 (fr) 1999-09-02 1999-09-02 Protéine liant l' Apoptin
EP99203465A EP1108785A1 (fr) 1999-10-21 1999-10-21 Protéine associée à l'apoptine

Publications (1)

Publication Number Publication Date
DK1083224T3 true DK1083224T3 (da) 2007-04-10

Family

ID=26153361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00203042T DK1083224T3 (da) 1999-09-02 2000-09-01 Apoptin-associerende protein

Country Status (20)

Country Link
US (2) US7317096B1 (fr)
EP (1) EP1083224B1 (fr)
JP (1) JP2003510030A (fr)
CN (1) CN100513565C (fr)
AT (1) ATE347597T1 (fr)
AU (1) AU781127B2 (fr)
BR (1) BR0013743A (fr)
CA (1) CA2383784A1 (fr)
CY (1) CY1106355T1 (fr)
DE (1) DE60032201T2 (fr)
DK (1) DK1083224T3 (fr)
EA (1) EA005933B1 (fr)
ES (1) ES2277815T3 (fr)
HU (1) HUP0202688A2 (fr)
IL (2) IL148469A0 (fr)
NO (1) NO20021067L (fr)
NZ (1) NZ517740A (fr)
PL (1) PL204275B1 (fr)
PT (1) PT1083224E (fr)
WO (1) WO2001016165A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2393859A1 (fr) * 1999-12-10 2001-06-14 Leadd B.V. Proteine associee a l'apoptine
MX2010011145A (es) 2008-04-11 2011-04-11 Merrimack Pharmaceuticals Inc Enlazadores de la albumina de suero humana y conjugados de la misma.
WO2011100428A2 (fr) * 2010-02-10 2011-08-18 The Uab Research Foundation Compositions visant à améliorer la masse osseuse

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
EP0878546A1 (fr) * 1997-04-15 1998-11-18 Leadd B.V. Véhicules de transfert de gènes exprimant la protéine VP2 induisant l'apoptose, et/ou l'apoptine
AU4388296A (en) 1994-12-22 1996-07-10 Novartis Ag Nuclear protein serine/threonine kinases
EP0830604B1 (fr) * 1995-06-07 2003-05-28 Leadd B.V. Utilisations de l'apoptine
WO1998039448A2 (fr) 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 nouvelles proteines secretees
NZ502800A (en) * 1997-08-12 2002-10-25 Leadd B The use of apoptin in determining the transforming capability of tumorigenic or tumor promoting agents
EP0927757A1 (fr) * 1997-12-03 1999-07-07 Leadd B.V. Méthodes et moyens pour induire l'apoptose par interférence avec des protéines similaires à Bip
EP0921192A1 (fr) 1997-12-03 1999-06-09 Leadd B.V. Molecules interagissant avec l'apoptine
EP0924296A3 (fr) * 1997-12-03 2001-08-01 Leadd B.V. Méthode et moyens d' induction de l'apoptose par interférence du traitement d'ARN
US20030105315A1 (en) 1998-04-09 2003-06-05 Metagen Pharmaceuticals Gmbh Human nucleic acid sequences from ovarian tumor tissue
WO1999057144A2 (fr) * 1998-05-05 1999-11-11 Incyte Pharmaceuticals, Inc. Molecules de regulateur de transcription humaine
CA2393859A1 (fr) 1999-12-10 2001-06-14 Leadd B.V. Proteine associee a l'apoptine
EP1111045A3 (fr) 1999-12-10 2001-09-19 Leadd B.V. Protéine associée à l'apoptine
EP1106691A1 (fr) 1999-12-10 2001-06-13 Leadd B.V. Protéine associée à l'apoptine
CA2397571A1 (fr) 2000-01-17 2001-07-26 Leadd B.V. Proteine s'associant a l'apoptine
EP1138765A1 (fr) 2000-03-27 2001-10-04 Leadd B.V. Protéines AAP-5 et AAP-6 associées à l'apoptine

Also Published As

Publication number Publication date
WO2001016165A2 (fr) 2001-03-08
CA2383784A1 (fr) 2001-03-08
NO20021067D0 (no) 2002-03-04
ATE347597T1 (de) 2006-12-15
CN1387569A (zh) 2002-12-25
JP2003510030A (ja) 2003-03-18
US7767790B2 (en) 2010-08-03
CY1106355T1 (el) 2011-10-12
NO20021067L (no) 2002-05-02
EP1083224A2 (fr) 2001-03-14
US20080176231A1 (en) 2008-07-24
NZ517740A (en) 2003-09-26
IL148469A (en) 2009-02-11
EA200200321A1 (ru) 2002-08-29
BR0013743A (pt) 2005-01-11
EA005933B1 (ru) 2005-08-25
WO2001016165A3 (fr) 2001-09-20
HUP0202688A2 (en) 2002-12-28
EP1083224A3 (fr) 2001-04-25
EP1083224B1 (fr) 2006-12-06
DE60032201T2 (de) 2007-09-20
AU781127B2 (en) 2005-05-05
DE60032201D1 (de) 2007-01-18
AU7324200A (en) 2001-03-26
US7317096B1 (en) 2008-01-08
PL354285A1 (en) 2003-12-29
ES2277815T3 (es) 2007-08-01
IL148469A0 (en) 2002-09-12
PT1083224E (pt) 2007-03-30
PL204275B1 (pl) 2009-12-31
CN100513565C (zh) 2009-07-15

Similar Documents

Publication Publication Date Title
DE60215848D1 (de) 1,2,4-thiadiazolverbindungen als melanocortinrezeptor-modulatoren
SV2003001144A (es) FORMAS CRISTALINAS DE LA SAL DE CALCIO DEL ACIDO [R-(R*,R*)]-2-(4-FLUOROFENIL)-ß,ô-DIHIDROXI-5-(1-METILETIL)-3-FENIL-4[(FENILAMINO)CARBONIL]-1H-PIRROL-1-HEPTANOICO (2:1) REF. PC430-01FJT
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
EA200400241A1 (ru) Направленные к мишени мультимерные контрастные вещества, основанные на пептидах
DK0713529T3 (da) Vækst-/differentieringsfaktor af TGF-beta-familien
EA200200105A1 (ru) СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ PPARγ;
PL339860A1 (en) Methods of modulating the action of serine/threonine protein kinase by means of compounds based on 5-azaquinoxaline
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
DE69232665D1 (de) Neue 4-arylpiperazine und 4-arylpiperidine
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
BG101002A (bg) Заместени арилалкилтио-алкилтиопиридини и използване за борба с бактерии от рода helicobacter
EA200000519A1 (ru) 2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
AT5762U3 (de) Entleerung von grossbehältern
ATE299183T1 (de) Apoptose induzierende proteinesubstanz
DK1083224T3 (da) Apoptin-associerende protein
EA200000520A1 (ru) 2-АРИЛ-3-АРОИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
DE60332579D1 (de) Prozess zur Immobilisierung von Polypeptiden über die Carboxylgruppe des C-terminus
AU2002257067A1 (en) Tsg101-gag interaction and use thereof
WO2001072825A3 (fr) Proteine d'association de l'apoptine
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
DE60038955D1 (de) AN DER OBERFLÄCHE VON KARZINOMZELLEN LOKALISIERTES COLLIGIN/HsP47
WO2001042461A3 (fr) Proteine associee a l'apoptine
EP1111045A3 (fr) Protéine associée à l'apoptine
WO2001053351A3 (fr) Proteine s'associant a l'apoptine
EP1138768A3 (fr) Protéine AAP-5 liant l' apoptine